Chemomab Therapeutics Ltd. (CMMB) Net Income by Year
Chemomab Therapeutics Ltd. reported a net loss of $9.0M in fiscal year 2025. This represents an increase of 35.5% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Chemomab Therapeutics Ltd. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CMMB Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
CMMB Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Chemomab Therapeutics Ltd. financials
Frequently Asked Questions
What was Chemomab Therapeutics Ltd.'s net income in fiscal year 2025?
Chemomab Therapeutics Ltd. reported a net loss of $9.0M in fiscal year 2025.
How fast is Chemomab Therapeutics Ltd.'s net income growing?
Chemomab Therapeutics Ltd. (CMMB) net income rose by 35.5% year over year, from -$13.9M to -$9.0M in fiscal year 2025.
How has Chemomab Therapeutics Ltd.'s net income changed over the years?
Across the 8 fiscal years this page covers, Chemomab Therapeutics Ltd. (CMMB) net income went from -$13.8M in fiscal year 2018 to -$9.0M in fiscal year 2025.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Chemomab Therapeutics Ltd. (CMMB) reported on that line in every period on record.